Meningococcal group A polysaccharide / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group W-135 / meningococcal polysaccharide vaccine group Y
RxNorm 1008395
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1008395 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: meningococcal group A polysaccharide / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group W-135 / meningococcal polysaccharide vaccine group Y.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Multiple Ingredients (MIN):
Meningococcal group A polysaccharide / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group W-135 / meningococcal polysaccharide vaccine group Y
(Atom ID: 12351981)
Patient Education
Meningococcal ACWY Vaccines (MenACWY)
What is meningococcal disease? Meningococcal disease is a serious illness caused by a type of bacteria called Neisseria meningitidis. It can lead to meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. Meningococcal disease often occurs without warning, even among people who are otherwise healthy. Meningococcal disease can spread from person to person through close contact (e.g., coughing, kissing) or lengthy contact, especially among people living in the same household. There are at least 12 types of N. meningitidis, called "serogroups." Serogroups A, B, C, W, and Y cause most meningococcal disease. Anyone can get meningococcal disease but certain people are at increased risk, including: Infants younger than one year old Adolescents and young adults 16 through 23 years old People with certain medical conditions that affect the immune system Microbiologists who routinely work with isolates of N. meningitidis People at risk because of a meningococcal outbreak in their community Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100. And of those who survive, about 10 to 20 out of every 100 will suffer disabilities such as hearing loss, brain damage, kidney damage, amputations, nervous system problems, or severe scars from skin grafts. Meningococcal ACWY vaccines can help prevent meningococcal disease caused by serogroups A, C, W, and Y. A different meningococcal vaccine is available to help protect against serogroup B.
[Learn More]
* Please review the disclaimer below.
